Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase
- 1 January 2018
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 143, 1667-1676
Abstract
No abstract availableKeywords
Funding Information
- Italian Government Project SIR (RBSI14C78S)
This publication has 36 references indexed in Scilit:
- Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymeraseBioorganic & Medicinal Chemistry, 2012
- Structure and functionality in flavivirus NS-proteins: Perspectives for drug designAntiviral Research, 2010
- An adenosine nucleoside inhibitor of dengue virusProceedings of the National Academy of Sciences, 2009
- The flavivirus polymerase as a target for drug discoveryAntiviral Research, 2008
- A Novel Approach to Pyrrolo[2,1-b][1,3]benzothiazinesSynthesis, 2008
- Benzothiazines in Organic Synthesis. Stereoselectivity in the Intermolecular Michael Addition Reactions of BenzothiazinesOrganic Letters, 2007
- Crystal Structure of the Dengue Virus RNA-Dependent RNA Polymerase Catalytic Domain at 1.85-Angstrom ResolutionJournal of Virology, 2007
- The Protein Data BankNucleic Acids Research, 2000
- A Fast Flexible Docking Method using an Incremental Construction AlgorithmJournal of Molecular Biology, 1996
- Preparation of some 4‐hydroxyl‐1‐methyl‐1H‐2,1‐benzothiazine‐3‐carboxanilide 2,2‐dioxidesJournal of Heterocyclic Chemistry, 1972